---
figid: PMC8027060__fonc-11-602194-g001
figlink: pmc/articles/PMC8027060/figure/f1/
number: Figure 1
caption: BRAF mutations promote the activation of this pathway and tumorigenesis.
  The molecular-targeted drugs developed to date for BRAF-mutated CRC are shown alongside
  the cascade.
pmcid: PMC8027060
papertitle: 'Management of BRAF Gene Alterations in Metastatic Colorectal Cancer:
  From Current Therapeutic Strategies to Future Perspectives.'
reftext: Hiroyuki Takeda, et al. Front Oncol. 2021;11:602194.
pmc_ranked_result_index: '56734'
pathway_score: 0.9391345
filename: fonc-11-602194-g001.jpg
figtitle: BRAF mutations promote the activation of this pathway and tumorigenesis
year: '2021'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8027060__fonc-11-602194-g001.html
  '@type': Dataset
  description: BRAF mutations promote the activation of this pathway and tumorigenesis.
    The molecular-targeted drugs developed to date for BRAF-mutated CRC are shown
    alongside the cascade.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EGFR
  - HRAS
  - KRAS
  - NRAS
  - BRAF
  - MAP2K1
  - MAP2K2
  - MAPK3
  - MAPK1
  - Encorafenib
  - Vemurafenib
  - Dabrafenib
  - Binimetinib
  - Trametinib
genes:
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: BRAF
  symbol: BRAF
  source: hgnc_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: BRAF
  symbol: BRAF
  source: hgnc_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: МЕК
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: МЕК
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
chemicals:
- word: Encorafenib
  source: ''
  identifier: ''
- word: Vemurafenib
  source: MESH
  identifier: C551177
- word: Dabrafenib
  source: MESH
  identifier: C561627
- word: Binimetinib
  source: MESH
  identifier: C581313
- word: Trametinib
  source: MESH
  identifier: C560077
diseases: []
---
